Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 41 studies | 48% ± 20% | |
| pericyte | 24 studies | 38% ± 17% | |
| smooth muscle cell | 15 studies | 33% ± 12% | |
| connective tissue cell | 12 studies | 56% ± 23% | |
| myofibroblast cell | 12 studies | 38% ± 18% | |
| adipocyte | 11 studies | 50% ± 15% | |
| endothelial cell | 10 studies | 35% ± 21% | |
| mesothelial cell | 8 studies | 35% ± 12% | |
| glial cell | 5 studies | 30% ± 16% | |
| adventitial cell | 5 studies | 34% ± 16% | |
| glutamatergic neuron | 5 studies | 28% ± 10% | |
| astrocyte | 4 studies | 30% ± 16% | |
| epithelial cell | 4 studies | 34% ± 24% | |
| hepatic stellate cell | 3 studies | 37% ± 14% | |
| interstitial cell of Cajal | 3 studies | 46% ± 4% | |
| neural crest cell | 3 studies | 28% ± 11% | |
| Schwann cell | 3 studies | 52% ± 18% | |
| GABAergic neuron | 3 studies | 20% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 9233.42 | 457 / 459 | 96% | 282.89 | 1072 / 1118 |
| lung | 99% | 9237.87 | 573 / 578 | 86% | 115.94 | 998 / 1155 |
| stomach | 94% | 6471.33 | 339 / 359 | 85% | 106.44 | 244 / 286 |
| intestine | 99% | 12938.84 | 961 / 966 | 79% | 95.57 | 416 / 527 |
| esophagus | 92% | 6891.91 | 1330 / 1445 | 85% | 132.59 | 155 / 183 |
| bladder | 100% | 11342.90 | 21 / 21 | 71% | 92.64 | 357 / 504 |
| uterus | 99% | 11752.98 | 169 / 170 | 62% | 104.41 | 283 / 459 |
| skin | 91% | 19524.06 | 1653 / 1809 | 64% | 70.98 | 304 / 472 |
| ovary | 99% | 7470.09 | 179 / 180 | 44% | 49.75 | 189 / 430 |
| thymus | 93% | 3685.68 | 610 / 653 | 26% | 18.60 | 159 / 605 |
| prostate | 95% | 5191.38 | 233 / 245 | 17% | 8.86 | 87 / 502 |
| pancreas | 12% | 394.19 | 39 / 328 | 94% | 236.03 | 167 / 178 |
| adipose | 100% | 11930.74 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 13968.80 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| heart | 78% | 3706.26 | 671 / 861 | 0% | 0 | 0 / 0 |
| kidney | 29% | 840.57 | 26 / 89 | 45% | 33.92 | 407 / 901 |
| tonsil | 0% | 0 | 0 / 0 | 73% | 88.65 | 33 / 45 |
| spleen | 71% | 1994.64 | 171 / 241 | 0% | 0 | 0 / 0 |
| adrenal gland | 34% | 798.55 | 88 / 258 | 17% | 13.02 | 39 / 230 |
| brain | 20% | 781.84 | 525 / 2642 | 29% | 24.32 | 206 / 705 |
| lymph node | 0% | 0 | 0 / 0 | 45% | 33.23 | 13 / 29 |
| liver | 10% | 304.45 | 22 / 226 | 27% | 17.02 | 109 / 406 |
| muscle | 16% | 454.00 | 125 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0001501 | Biological process | skeletal system development |
| GO_1903225 | Biological process | negative regulation of endodermal cell differentiation |
| GO_0030199 | Biological process | collagen fibril organization |
| GO_0030198 | Biological process | extracellular matrix organization |
| GO_0001503 | Biological process | ossification |
| GO_0071230 | Biological process | cellular response to amino acid stimulus |
| GO_0043588 | Biological process | skin development |
| GO_0048592 | Biological process | eye morphogenesis |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005592 | Cellular component | collagen type XI trimer |
| GO_0005788 | Cellular component | endoplasmic reticulum lumen |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005588 | Cellular component | collagen type V trimer |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0031012 | Cellular component | extracellular matrix |
| GO_0030020 | Molecular function | extracellular matrix structural constituent conferring tensile strength |
| GO_0046332 | Molecular function | SMAD binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | COL5A2 |
| Protein name | COL5A2 protein Collagen alpha-2(V) chain Collagen type V alpha 2 chain |
| Synonyms | |
| Description | FUNCTION: Type V collagen is a member of group I collagen (fibrillar forming collagen). It is a minor connective tissue component of nearly ubiquitous distribution. Type V collagen binds to DNA, heparan sulfate, thrombospondin, heparin, and insulin. Type V collagen is a key determinant in the assembly of tissue-specific matrices (By similarity). . FUNCTION: Type I collagen is a member of group I collagen (fibrillar forming collagen). . FUNCTION: Type I collagen is a member of group I collagen (fibrillar forming collagen). . |
| Accessions | ENST00000374866.9 A0A087WYX9 P05997 Q5PR22 ENST00000618828.1 ENST00000649966.1 A0A3B3IRH9 |